References
- Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang LJ, Huang JF. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001;221:167–172.
- Herrera LJ, Fernando HC, Perry Y, Gooding WE, Buenaventura PQ, Christie NA, Luketich JD. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. Journal of Thoracic and Cardiovascular Surgery 2003;125:929–937.
- Highland AM, Mack P, Breen DJ. Radiofrequency thermal ablation of a metastatic lung nodule. European Radiology 2002;12 (suppl.) :S166–170.
- McCann C, Kumaradas JC, Gertner MR, Davidson SR, Dolan AM, Sherar MD. Feasibility of salvage interstitial microwave thermal therapy for prostate carcinoma following failed brachytherapy: studies in a tissue equivalent phantom. Physics in Medicine and Biology 2003;48:1041–1052.
- Dong BW, Zhang J, Liang P, Yu XL, Su L, Yu DJ, Ji XL, Yu G. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. International Journal of Hyperthermia 2003;19:119–133.
- Nakayama J, Urabe A, Terao H, Taniguchi S, Hon Y. In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia. Pigment Cell Research 1993;6: 111–116.
- Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. Journal of Experimental Medicine 2000;191:411–416.
- Sauter B, Albert ML, Francisco L, Larsson M, Somersan S, Bhardwaj N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. Journal of Experimental Medicine 2000;191:423–433.
- Barker RN, Erwig L, Pearce WP, Devine A, Rees AJ. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology 1999;67:302–305.
- Reiter I, Krammer B, Schwamberger G. Differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities. Journal of Immunology 1999;163:1730–1732.
- Horton HM, Dorigo 0, Hernandez P, Anderson D, Berek JS, Parker SE. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile. Journal of Immunology 1999;163: 6378–6385.
- Thomas MC, Greten TF, Pardoll DM, Jaffee EM. Enhanced tumor protection by granulocyte-macrophage colony-stimulating factor expression at the site of an allogeneic vaccine. Human Gene Therapy 1998;9:835–843.
- von Mehren M, Arlen P, Gulley J, Rogatko A, Cooper HS, Meropol NJ, Alpaugh RK, Davey M, McLaughlin S, Beard MT, Tsang KY, Schlom J, Weiner LM. The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma. Clinical Cancer Research 2001;7: 1181–1191.